PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can avastin stop hidden ovarian cancer after second-look surgery?
Disease control OngoingThis study tests whether the drug bevacizumab (Avastin) can help control ovarian, fallopian tube, or primary peritoneal cancer that was still found during a second-look surgery. About 35 adults with advanced-stage cancer who already had standard chemotherapy and surgery will rece…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
Ovarian cancer drug study pulled before it began
Disease control TerminatedThis study was designed to test an experimental drug called BAT8006 in people with ovarian cancer that no longer responds to platinum-based chemotherapy. The goal was to find a safe dose and see if the drug could shrink tumors. However, the study was withdrawn before any particip…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New gene therapy shows promise in ovarian cancer fight
Disease control OngoingThis study tests a new treatment called IMNN-001, a gene therapy given directly into the abdomen, combined with standard chemotherapy for people newly diagnosed with advanced ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the combination helps people…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for Platinum-Resistant ovarian cancer? small study tests Triple-Drug attack
Disease control OngoingThis early-phase study tested whether adding zoledronic acid to standard chemotherapy (paclitaxel) and a targeted therapy (bevacizumab) could help women with ovarian cancer that no longer responds to platinum drugs. Only 14 women participated, and the main goal was to see how the…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New hope for ovarian cancer: targeted drug combo shows promise in Mid-Stage trial
Disease control OngoingThis study tests a two-step treatment for a type of ovarian cancer that has come back after initial chemotherapy. First, patients receive a standard chemo drug (carboplatin) plus a targeted drug (mirvetuximab soravtansine) that attacks cancer cells with a specific marker (FRα). T…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC